Malattia ipertensiva e progressione del danno d'organo.

Translated title of the contribution: Hypertension and the progression of organ damage

A. Morganti

Research output: Contribution to journalArticle

Abstract

The heart is one of the most important targets of arterial hypertension to which this organ responds with the development of left ventricular hypertrophy. This structural alteration, which is rather frequent already in the early stages of hypertension, derives from a complex interaction of hemodynamic and humoral factors and represents a compensatory mechanism for maintaining a normal cardiac output in spite of the elevated peripheral resistance; yet, with time, left ventricular hypertrophy exposes patients to an additive risk of ischemia, dysrhythmias and cardiac failure. However the progression towards these clinical manifestations of cardiac deterioration is susceptible nowadays to be halted thanks to the efficacy of antihypertensive drugs and particularly of those antagonizing the activity of the renin-angiotensin system.

Original languageItalian
Pages (from-to)100-103
Number of pages4
JournalItalian Heart Journal
Volume1 Suppl 2
Publication statusPublished - Jun 2000

Fingerprint

Left Ventricular Hypertrophy
Hypertension
Renin-Angiotensin System
Cardiac Output
Vascular Resistance
Antihypertensive Agents
Ischemia
Heart Failure
Hemodynamics

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Malattia ipertensiva e progressione del danno d'organo. / Morganti, A.

In: Italian Heart Journal, Vol. 1 Suppl 2, 06.2000, p. 100-103.

Research output: Contribution to journalArticle

Morganti, A 2000, 'Malattia ipertensiva e progressione del danno d'organo.', Italian Heart Journal, vol. 1 Suppl 2, pp. 100-103.
Morganti, A. / Malattia ipertensiva e progressione del danno d'organo. In: Italian Heart Journal. 2000 ; Vol. 1 Suppl 2. pp. 100-103.
@article{ec2e425dfe674597aa78db4c63323c9c,
title = "Malattia ipertensiva e progressione del danno d'organo.",
abstract = "The heart is one of the most important targets of arterial hypertension to which this organ responds with the development of left ventricular hypertrophy. This structural alteration, which is rather frequent already in the early stages of hypertension, derives from a complex interaction of hemodynamic and humoral factors and represents a compensatory mechanism for maintaining a normal cardiac output in spite of the elevated peripheral resistance; yet, with time, left ventricular hypertrophy exposes patients to an additive risk of ischemia, dysrhythmias and cardiac failure. However the progression towards these clinical manifestations of cardiac deterioration is susceptible nowadays to be halted thanks to the efficacy of antihypertensive drugs and particularly of those antagonizing the activity of the renin-angiotensin system.",
author = "A. Morganti",
year = "2000",
month = "6",
language = "Italian",
volume = "1 Suppl 2",
pages = "100--103",
journal = "Italian Heart Journal",
issn = "1129-471X",
publisher = "Societa Italiana di Cardiologia",

}

TY - JOUR

T1 - Malattia ipertensiva e progressione del danno d'organo.

AU - Morganti, A.

PY - 2000/6

Y1 - 2000/6

N2 - The heart is one of the most important targets of arterial hypertension to which this organ responds with the development of left ventricular hypertrophy. This structural alteration, which is rather frequent already in the early stages of hypertension, derives from a complex interaction of hemodynamic and humoral factors and represents a compensatory mechanism for maintaining a normal cardiac output in spite of the elevated peripheral resistance; yet, with time, left ventricular hypertrophy exposes patients to an additive risk of ischemia, dysrhythmias and cardiac failure. However the progression towards these clinical manifestations of cardiac deterioration is susceptible nowadays to be halted thanks to the efficacy of antihypertensive drugs and particularly of those antagonizing the activity of the renin-angiotensin system.

AB - The heart is one of the most important targets of arterial hypertension to which this organ responds with the development of left ventricular hypertrophy. This structural alteration, which is rather frequent already in the early stages of hypertension, derives from a complex interaction of hemodynamic and humoral factors and represents a compensatory mechanism for maintaining a normal cardiac output in spite of the elevated peripheral resistance; yet, with time, left ventricular hypertrophy exposes patients to an additive risk of ischemia, dysrhythmias and cardiac failure. However the progression towards these clinical manifestations of cardiac deterioration is susceptible nowadays to be halted thanks to the efficacy of antihypertensive drugs and particularly of those antagonizing the activity of the renin-angiotensin system.

UR - http://www.scopus.com/inward/record.url?scp=0034199465&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034199465&partnerID=8YFLogxK

M3 - Articolo

C2 - 10905136

AN - SCOPUS:0034199465

VL - 1 Suppl 2

SP - 100

EP - 103

JO - Italian Heart Journal

JF - Italian Heart Journal

SN - 1129-471X

ER -